middle.news
TrivarX Secures Supply for Stabl-Im Phase 1 Trial in 2026
9:15am on Thursday 16th of July, 2026 AEST
•
Healthcare
Read Story
TrivarX Secures Supply for Stabl-Im Phase 1 Trial in 2026
9:15am on Thursday 16th of July, 2026 AEST
Key Points
Investigational product supply secured for Phase 1 trial
Trial aims to generate human safety and imaging data
Stabl-Im offers non-radioactive tumour biology imaging
Clinical trial prep includes protocol finalisation and site engagement
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Trivarx (ASX:TRI)
OPEN ARTICLE